EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?

MariaYu Konoshenko iD, Pavel Laktionov, Olga Bryzgunova

Andrology · 2024

DOI: 10.1111/andr.13535 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Andrology, 2024. Verfasst von MariaYu Konoshenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Russian Science Foundation, Government of the Novosibirsk Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radical prostatectomy, radiotherapy, chemotherapy, and androgen‐deprivation therapy are among the most common treatment options for different forms of prostate cancer (PCa). However, making therapeutic decisions is difficult due to the lack of reliable prediction markers indicating therapy outcomes in clinical practice. The involvement of miRNAs in all mechanisms of the PCa development and their easy detection characterize them as attractive PCa biomarkers. Although there are extensive data on the role of miRNAs in PCa therapy resistance and sensitivity development, the issues of whether they could be used as a guide for therapy choice and, if so, how we can progress toward this goal, remain unclear. Thus, generalizable reviews and studies which summarize, compare, and analyze data on miRNA involvement in responses to different types of PCa therapies are required.

Objectives

Data on the involvement of miRNAs in therapy responses, on the role of cross‐miRNA expression in different therapies, and on miRNA targets were analyzed in order to determine the miRNA‐related factors which can lend perspective to the future development of personalized predictors of PCa sensitivity/resistance to therapies. Materials and methods The data available on the miRNAs associated with different PCa therapies (resistance and sensitivity therapies) are summarized and analyzed in this study, including analyses using bioinformatics resources. Special attention was dedicated to the mechanisms of the development of therapy resistance. Results and discussion A comprehensive combined analysis of the current data revealed a panel of miRNAs that were shown to be most closely associated with the PCa therapy response and were found to regulate the genes involved in PCa development via cell proliferation regulation, epithelial‐mesenchymal transition (EMT), apoptosis, cell‐cycle progression, angiogenesis, metastasis and invasion regulation, androgen‐independent development, and colony formation.

Conclusion

The selected miRNA‐based panel has the potential to be a guide for therapeutic decision making in the effective treatment of PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsMaleHumansAndrogensAndrogen AntagonistsProstateGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

chemotherapymiRNAprostate cancerprostatectomyradiotherapytherapy resistance

Substanzen

MicroRNAsAndrogensAndrogen Antagonists

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia.

ORCID-Profile: MariaYu Konoshenko

Förderung

  • Russian Science Foundation
  • Government of the Novosibirsk Region

Zitieren

APA

Konoshenko, M., Laktionov, P., & Bryzgunova, O. (2024). Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?. Andrology. https://doi.org/10.1111/andr.13535

Vancouver

Konoshenko M, Laktionov P, Bryzgunova O. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?. Andrology. 2024. doi:10.1111/andr.13535

BibTeX
@article{Konoshenko2024,
  author = {Konoshenko, MariaYu and Laktionov, Pavel and Bryzgunova, Olga},
  title = {Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13535}
}
Kostenlos starten →